Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of P4HA1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of P4HA1 mRNA | decreases expression | 20406850
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of P4HA1 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of P4HA1 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of P4HA1 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of P4HA1 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of P4HA1 mRNA | decreases expression | 19654921
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of P4HA1 mRNA | decreases expression | 15725085
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of P4HA1 mRNA | decreases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of P4HA1 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of P4HA1 mRNA | decreases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of P4HA1 mRNA | increases expression | 19638242
|
D001556 |
Lindane |
Lindane results in decreased expression of P4HA1 mRNA | decreases expression | 17785943
|
D008942 |
Mitoxantrone |
P4HA1 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
C030110 |
oxaliplatin |
oxaliplatin results in decreased expression of P4HA1 mRNA | decreases expression | 17762391
|
C041786 |
palm oil |
palm oil results in decreased expression of P4HA1 mRNA | decreases expression | 18042831
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of P4HA1 mRNA | increases expression | 18158353
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of P4HA1 mRNA | increases expression | 18301758
|
C002979 |
selenomethylselenocysteine |
selenomethylselenocysteine results in increased expression of P4HA1 mRNA | increases expression | 18514395
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of P4HA1 mRNA | affects expression | 19590694
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of P4HA1 mRNA | increases expression | 18514395
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of P4HA1 mRNA | decreases expression | 16443690 18495758
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of P4HA1 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of P4HA1 mRNA] | decreases reaction|increases expression | 15667827
|
C066340 |
tolcapone |
tolcapone binds to P4HA1 protein | affects binding | 19783845
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.72 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.43 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.99 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.26 | 19825857 11798837 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.78 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
16.52 | 17162532 19061943 17620307 19052882 16434500 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
16.52 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.52 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.57 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
13.36 | 17306315 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
13.36 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
4.24 | 12661182 |
MESH:D017109 |
Akathisia, Drug-Induced |
|
tolcapone |
6.16 | 11080934 |
MESH:D000544 |
Alzheimer Disease |
|
tolcapone |
3.25 | 20150427 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.83 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.71 | 10982225 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
4.00 | 17460149 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.83 | 18414634 12569548 16251483 16835338 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.76 | 15238619 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.17 | 19371607 12928151 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
14.58 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.58 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.58 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.66 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.68 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.41 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.33 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.33 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
2.33 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
selenomethylselenocysteine |
2.33 | 18855134 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.33 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.20 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.69 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.52 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
16.58 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
16.58 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
16.58 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
16.58 | 12907637 12619106 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
16.58 | 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
16.58 | 14691202 15553829 16217749 11135700 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
16.58 | 17138121 16807293 19383236 21159647 16569478 18785209 20101231 19519916 19107877 20007298 17978847 19539802 10737359 16540662 19919837 20935162 18691550 19822196 16502159 19701751 18788625 16779866 16328049 3084413 16878318 19394651 18506893 16830150 19208518 3581430 20512989 17428255 17055752 18210153 10672840 19335982 17173139 16698587 16681979 11831363 17162532 19418558 16288022 18978308 17761372 20084675 18056438 19052882 16935385 20524982 18665156 18971187 20432363 20214788 18494052 18393292 20514400 19171122 20727157 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
16.58 | 17306315 16507464 15276417 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.75 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.00 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.71 | 17687452 15504454 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.71 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
3.96 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
6.64 | 11179087 15728586 11754973 17287366 17124262 16170337 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.64 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.36 | 15738583 19152805 17938729 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.20 | 18022660 16973168 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.51 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.28 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.28 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
15.28 | 21159647 7505956 2727394 17174075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.28 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.95 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.95 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.43 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.43 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.62 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.05 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
3.15 | 16510598 16004971 16024531 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.86 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
2.86 | 18448328 18509181 17255274 17695437 17594712 17401013 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.95 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.06 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.43 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.43 | 20055451 10048152 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.46 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.46 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.97 | 15213294 |
MESH:D003866 |
Depressive Disorder |
|
tolcapone |
4.21 | 11224284 7768276 |
MESH:D003865 |
Depressive Disorder, Major |
|
tolcapone |
4.79 | 10440460 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.37 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.66 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.11 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.11 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
18.09 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
18.09 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
18.09 | 14725611 16177239 16485898 17906064 12705907 16227642 18713872 12594235 19370779 19739265 15619225 14986274 11529661 11421492 17562736 16081117 10663392 17522070 18071297 19085960 11461765 16109766 16393943 19923254 19420014 12958197 12392966 19164858 12540782 10915739 10774834 19416960 16781746 11287661 12153990 2444490 11739529 15968718 11743745 11834606 14550746 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
18.09 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
18.09 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
18.09 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
tolcapone |
18.09 | 16604736 19783845 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.97 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.66 | 11462148 |
MESH:D004409 |
Dyskinesia, Drug-Induced |
|
tolcapone |
5.27 | 11455177 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.36 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.14 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.14 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.77 | 15322242 16714409 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.91 | 9294722 10568697 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.99 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
2.28 | 12903497 |
MESH:D054908 |
Extensively Drug-Resistant Tuberculosis |
|
tolcapone |
5.82 | 19578428 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
23.36 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
23.36 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
23.36 | 18296743 19551842 17967931 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
23.36 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
23.36 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.33 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.96 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
13.96 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.96 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.43 | 6392382 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.13 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.55 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.55 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.09 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.47 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.26 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.06 | 16019553 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.46 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.29 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.21 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.83 | 16221962 19772884 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.83 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.04 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.92 | 18606429 16959395 15340226 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.70 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
7.70 | 17418472 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.47 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.07 | 20558911 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.34 | 17050553 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.49 | 21332399 |
MESH:D006973 |
Hypertension |
|
Arsenic |
11.98 | 11953799 9931084 16076760 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
11.98 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.98 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.43 | 18502941 12791704 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.43 | 16093927 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.90 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.88 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
7.88 | 18785209 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.88 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
11.84 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.84 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
11.84 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.31 | 15604871 |
MESH:D007642 |
Keratosis |
|
Arsenic |
4.86 | 12749816 16930632 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.57 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.57 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.57 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
11.74 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.74 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.74 | 12371664 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.77 | 15070760 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.73 | 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.67 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.18 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.33 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.64 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.12 | 16467208 17050201 19850784 16968895 20471514 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
7.50 | 17339181 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.50 | 19035177 19075265 9834237 11161223 12712474 16330433 19642359 16966277 16331271 15622746 17217047 17869043 16891316 12679006 15213294 19225113 12018890 15336539 17107899 16823087 17649720 16112521 15748426 11468182 17712046 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.22 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.40 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.40 | 18522880 18407596 20032147 19638242 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.09 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.09 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
9.15 | 19014921 19460945 19784758 16610002 16611625 12587719 12969438 11587558 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
9.15 | 11134558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
9.15 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
9.15 | 1715830 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.12 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
25.12 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
25.12 | 18177683 2125692 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
25.12 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
25.12 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
25.12 | 20452335 2862719 19850985 19996281 18648771 20492335 20501860 21071580 21278145 21047994 20118626 21167192 20101389 19090486 15885732 19427195 19254457 19551842 19812893 20583210 19499222 19642983 18978307 18644402 12771043 9163691 20434301 19256749 19638242 19690152 19294768 20405173 12112319 19073162 20137499 19255062 15175105 2422723 18977376 16942905 19426721 10737359 19833225 18754104 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
25.12 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
25.12 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
25.12 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
17.78 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
17.78 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
17.78 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
17.78 | 18164116 17854601 17942915 19004024 16842330 19539802 18282651 19009564 18093689 16267830 18308698 18544905 3124819 17174075 9362446 18775883 19126423 2563599 18253720 18079962 19519916 21159647 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.78 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.25 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.08 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.35 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
8.35 | 17976673 17306315 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
8.35 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.35 | 21163286 20970405 6695378 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.35 | 16712894 17306315 15276417 19931552 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.35 | 11884234 19555203 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.93 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
selenomethylselenocysteine |
4.13 | 15318939 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.02 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.44 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.66 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.01 | 15949261 19417148 14977855 19549372 11468182 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.38 | 16239165 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.54 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.07 | 16105982 16882451 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.09 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
8.65 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.65 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.84 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.91 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.91 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.83 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.52 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
Lindane |
11.42 | 12807735 16818664 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
11.42 | 16640825 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.42 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.42 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.54 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.31 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.17 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.09 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
11.72 | 16620997 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
11.72 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.72 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.82 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.82 | 20387270 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.25 | 17056641 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.99 | 20387270 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.32 | 11836018 20132043 19632207 21332399 16723640 17217161 20518802 18674790 18457598 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.32 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.50 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.50 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
7.71 | 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
7.71 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.71 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.29 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.12 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
5.12 | 16540662 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.04 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
tolcapone |
3.55 | 7566641 9591521 18328768 9708959 10651109 8635184 11746615 1977408 11586115 11432539 8739811 9305320 19783845 9333106 19578428 16758261 9754991 11793426 20334432 20216409 17089403 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.12 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.05 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
4.86 | 6392382 15371236 16905509 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.43 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.57 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.57 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.06 | 11896295 11222880 11118676 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
1.90 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.90 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
1.90 | 12661182 14688026 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.90 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
1.90 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
3.88 | 21343184 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.32 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.83 | 16646077 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.42 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.42 | 18551238 |
MESH:D012640 |
Seizures |
|
Lindane |
9.42 | 15475178 7539098 12842176 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.57 | 7327846 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.71 | 15952646 19834688 16702368 17938729 17548696 18709164 16353154 17453740 17050553 6392382 16759981 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
13.08 | 17029826 15504454 16251483 19538983 17050553 17976673 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.08 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.08 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.08 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.69 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.41 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.41 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.77 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
6.86 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.86 | 7505956 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.83 | 15213294 |
MESH:D018088 |
Tuberculosis, Multidrug-Resistant |
|
tolcapone |
5.82 | 19578428 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
15.27 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.27 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
15.27 | 11144890 18640142 19322015 17306315 17976673 19429237 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
15.27 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
15.27 | 17306315 16452187 16712894 11723127 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.55 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.55 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.85 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.65 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.85 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
11.41 | 17056641 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
11.41 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.47 | 12125929 |
MESH:D014820 |
Vitiligo |
|
tolcapone |
5.06 | 10573327 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.12 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.62 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.31 | 17120751 |